Nanobiotix S.A. American Depositary Shares (NBTX)

About NBTX

Nanobiotix S.A. operates as a clinical-stage biotechnology that focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck, liver, prostate, pancreatic, esophageal, rectal, and non-small cell lung cancer. The…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

100

Website

www.nanobiotix.com

Fundamentals

1-day range

$42.65$45.74

Market cap

$1.83B

P/E (trailing)

—

P/E (forward)

-133.74

EPS (trailing)

$-0.50

Dividend yield

—

Beta

-0.35

Avg. volume

110.1K

Forecasts

3 analyst ratings

Nanobiotix S.A. American Depositary Shares Competitors

Chosen by industry and closest market cap.

• NBTX

  Nanobiotix S.A. American Depositary Shares

  $41.28

  ▼ 8.59%
  Market cap $1.83BP/E —
  $7.02$47.66
• CMPS

  COMPASS Pathways Plc American Depository Shares

  $13.71

  ▼ 6.35%
  Market cap $1.83BP/E —
  $4.4$15.4
• BCAX

  Bicara Therapeutics Inc. Common Stock

  $23.42

  ▼ 5.70%
  Market cap $1.81BP/E —
  $10.3$30.99
• ANIP

  ANI Pharmaceuticals Inc.

  $72.83

  ▼ 0.93%
  Market cap $1.86BP/E 18.72
  $70.15$99.5
• GENB

  Generate Biomedicines Inc. Common Stock

  $15.33

  ▼ 2.79%
  Market cap $1.78BP/E —
  $11$22.67
• SRPT

  Sarepta Therapeutics Inc. Common Stock (DE)

  $20.85

  ▼ 3.43%
  Market cap $1.77BP/E —
  $14.68$25.32
• SNDX

  Syndax Pharmaceuticals Inc. Common Stock

  $19.55

  ▼ 3.05%
  Market cap $1.76BP/E —
  $12.99$25.59

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• 12 Health Care Stocks Moving In Monday's Intraday Session
  Benzinga · 8/17/2026

Institutional Ownership

March 31, 2026

Total shares held

5.70M

Total value held

$175.90M

Institutional holders

15